Skip to Content

6 Results Found

  • Article
  • Open Access
2 Citations
2,956 Views
14 Pages

Expression of BARD1 β Isoform in Selected Pediatric Tumors

  • Anna Jasiak,
  • Natalia Krawczyńska,
  • Mariola Iliszko,
  • Katarzyna Czarnota,
  • Kamil Buczkowski,
  • Joanna Stefanowicz,
  • Elżbieta Adamkiewicz-Drożyńska,
  • Grzegorz Cichosz and
  • Ewa Iżycka-Świeszewska

26 January 2021

Currently, many new possible biomarkers and mechanisms are being searched and tested to analyse pathobiology of pediatric tumours for the development of new treatments. One such candidate molecular factor is BARD1 (BRCA1 Associated RING Domain 1)—a t...

  • Brief Report
  • Open Access
5 Citations
4,311 Views
10 Pages

Differential Expression of BARD1 Isoforms in Melanoma

  • Lorissa I. McDougall,
  • Ryan M. Powell,
  • Magdalena Ratajska,
  • Chi F. Lynch-Sutherland,
  • Sultana Mehbuba Hossain,
  • George A. R. Wiggins,
  • Agnieszka Harazin-Lechowska,
  • Bożena Cybulska-Stopa,
  • Jyoti Motwani and
  • Michael R. Eccles
  • + 4 authors

23 February 2021

Melanoma comprises <5% of cutaneous malignancies, yet it causes a significant proportion of skin cancer-related deaths worldwide. While new therapies for melanoma have been developed, not all patients respond well. Thus, further research is requir...

  • Article
  • Open Access
8 Citations
4,047 Views
22 Pages

HuR Plays a Role in Double-Strand Break Repair in Pancreatic Cancer Cells and Regulates Functional BRCA1-Associated-Ring-Domain-1(BARD1) Isoforms

  • Aditi Jain,
  • Matthew McCoy,
  • Carolyn Coats,
  • Samantha Z. Brown,
  • Sankar Addya,
  • Carl Pelz,
  • Rosalie C. Sears,
  • Charles J. Yeo and
  • Jonathan R. Brody

6 April 2022

Human Antigen R (HuR/ELAVL1) is known to regulate stability of mRNAs involved in pancreatic ductal adenocarcinoma (PDAC) cell survival. Although several HuR targets are established, it is likely that many remain currently unknown. Here, we identified...

  • Review
  • Open Access
18 Citations
6,320 Views
25 Pages

The Effects of Genetic and Epigenetic Alterations of BARD1 on the Development of Non-Breast and Non-Gynecological Cancers

  • Andrea K. Watters,
  • Emily S. Seltzer,
  • Danny MacKenzie,
  • Melody Young,
  • Jonathan Muratori,
  • Rama Hussein,
  • Andrej M. Sodoma,
  • Julie To,
  • Manrose Singh and
  • Dong Zhang

21 July 2020

Breast Cancer 1 (BRCA1) gene is a well-characterized tumor suppressor gene, mutations of which are primarily found in women with breast and ovarian cancers. BRCA1-associated RING domain 1 (BARD1) gene has also been identified as an important tumor su...

  • Review
  • Open Access
19 Citations
5,460 Views
12 Pages

BARD1 and Breast Cancer: The Possibility of Creating Screening Tests and New Preventive and Therapeutic Pathways for Predisposed Women

  • Marcin Śniadecki,
  • Michał Brzeziński,
  • Katarzyna Darecka,
  • Dagmara Klasa-Mazurkiewicz,
  • Patryk Poniewierza,
  • Marta Krzeszowiec,
  • Natalia Kmieć and
  • Dariusz Wydra

24 October 2020

Current oncological developments are based on improved understanding of genetics, and especially the discovery of genes whose alterations affect cell functions with consequences for the whole body. Our work is focused on the one of these genes, BRCA1...

  • Review
  • Open Access
1,569 Views
23 Pages

17 September 2025

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive solid malignancy with poor overall prognosis and limited response to standard treatments. Growing interest in the modulation of DNA repair mechanisms, including the homologous recombination (HR...